Norman R. Hames Sells 5,000 Shares of RadNet Inc. (NASDAQ:RDNT) Stock

RadNet Inc. (NASDAQ:RDNT) EVP Norman R. Hames sold 5,000 shares of the firm’s stock in a transaction on Wednesday, December 20th. The stock was sold at an average price of $9.96, for a total value of $49,800.00. Following the completion of the sale, the executive vice president now directly owns 365,087 shares of the company’s stock, valued at approximately $3,636,266.52. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Shares of RadNet Inc. (NASDAQ RDNT) traded down $0.35 during mid-day trading on Friday, hitting $10.30. The stock had a trading volume of 121,584 shares, compared to its average volume of 192,619. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 7.88. RadNet Inc. has a fifty-two week low of $5.25 and a fifty-two week high of $11.90. The firm has a market cap of $507.20, a PE ratio of 44.78, a PEG ratio of 2.32 and a beta of 0.83.

RadNet (NASDAQ:RDNT) last announced its quarterly earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.12. RadNet had a return on equity of 23.73% and a net margin of 1.21%. The firm had revenue of $227.60 million during the quarter, compared to analyst estimates of $232.84 million. During the same quarter in the previous year, the business earned $0.11 EPS. RadNet’s revenue for the quarter was up 1.3% compared to the same quarter last year. research analysts expect that RadNet Inc. will post 0.35 EPS for the current year.

Several institutional investors have recently made changes to their positions in RDNT. Dimensional Fund Advisors LP increased its stake in RadNet by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,531,850 shares of the medical research company’s stock worth $11,872,000 after buying an additional 112,194 shares in the last quarter. Vanguard Group Inc. increased its stake in RadNet by 4.2% during the 2nd quarter. Vanguard Group Inc. now owns 1,284,852 shares of the medical research company’s stock worth $9,957,000 after buying an additional 51,229 shares in the last quarter. State Street Corp increased its stake in RadNet by 9.2% during the 2nd quarter. State Street Corp now owns 585,218 shares of the medical research company’s stock worth $4,538,000 after buying an additional 49,186 shares in the last quarter. JPMorgan Chase & Co. increased its stake in RadNet by 85.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 503,880 shares of the medical research company’s stock worth $5,795,000 after buying an additional 232,524 shares in the last quarter. Finally, Northern Trust Corp increased its stake in RadNet by 5.2% during the 2nd quarter. Northern Trust Corp now owns 436,407 shares of the medical research company’s stock worth $3,382,000 after buying an additional 21,746 shares in the last quarter. Hedge funds and other institutional investors own 53.16% of the company’s stock.

A number of analysts have commented on RDNT shares. Zacks Investment Research raised RadNet from a “sell” rating to a “hold” rating in a research report on Wednesday, October 25th. BidaskClub raised RadNet from a “sell” rating to a “hold” rating in a research report on Saturday, January 6th. Finally, TheStreet cut RadNet from a “b-” rating to a “c” rating in a research report on Friday, October 27th.

WARNING: This article was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/14/norman-r-hames-sells-5000-shares-of-radnet-inc-rdnt-stock.html.

About RadNet

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply